Tectonic Therapeutic (TECX) Cash from Investing Activities (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Cash from Investing Activities came in at -$19000.0 in Q1 2026, up 29.63% year-on-year from -$14657.1 in Q1 2025, and up 88.55% on a QoQ basis from -$166000.0 in Q3 2025.
Tectonic Therapeutic (TECX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Cash from Investing Activities data on file, last reported at -$19000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 29.63% year-over-year to -$19000.0 in Q1 2026; TTM through Mar 2026 was -$130000.0, a 27.37% increase from a year earlier, with the FY2025 full-year figure at -$138000.0, up 11.54% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$19000.0, up from -$166000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for TECX reached as high as $55000.0 in Q2 2025 and fell as low as -$214000.0 in Q2 2023.
- Historically, Cash from Investing Activities has averaged -$57266.7 across 5 years, with a median of -$27000.0 in 2025.
- Across the five-year window, Cash from Investing Activities sank 2085.71% in 2024 and jumped 1275.0% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$86000.0 in 2022, then jumped by 41.86% to -$50000.0 in 2023, then surged by 94.0% to -$3000.0 in 2024, then tumbled by 5433.33% to -$166000.0 in 2025, then jumped by 88.55% to -$19000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$19000.0 in Q1 2026, -$166000.0 in Q3 2025, and $55000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -45.51 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 178,242.27 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 172.62 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Sep 30, 2023 | -7,000.00 |